Modelling How Refractoriness to Interferon Compromises Interferon-Free Treatment of Hepatitis C Virus Infection

Modelling How Refractoriness to Interferon Compromises Interferon-Free Treatment of Hepatitis C Virus Infection

Hepatitis C virus (HCV) infection globally affects 130-150 million people. It causes both acute and chronic infections. Due to the severe side effects and low success rates of interferon based treatments, which formed the standard treatment for HCV, the treatment paradigm shifted to direct acting an...

Full description

Bibliographic Details
Main Author: Venugopal, Vishnu
Other Authors: Dixit, Narendra
Language:en_US
Published: 2018
Subjects:
HCV Lifecycle
Hepatitis C Virus Infection
Multiple Loci
DAA Based Treatment
RAVs
HCV Kinetics
Direct Acting Antivirals (DAAs)
Interferon-Free Treatment
Chemical Engineering
Online Access:http://etd.iisc.ernet.in/2005/3612
http://etd.iisc.ernet.in/abstracts/4481/G28483-Abs.pdf

Internet

http://etd.iisc.ernet.in/2005/3612
http://etd.iisc.ernet.in/abstracts/4481/G28483-Abs.pdf

Similar Items